This website uses functional cookies, including analytical cookies. The obtained statistical data cannot be traced back to individual users. Additionally, you can choose to accept or refuse consent to use marketing cookies. If you decline these additional cookies or refrain from making a choice, only functional cookies will be set. See our cookie policy for more information.
A four-year research project by INSEAD and five other institutions (incl RSM) sheds light on how understanding medical criticality, supply chain risk and their interactions could help us better address drug shortages. Research co-authored by RSM's Harwin de Vries and Stef Lemmens.
Read the article: https://sfbn.org/san-francisco-biotech-news/2024/07/18/assessment-of-supply-chain-risk-key-to-improving-medicine-access/